Image

Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients

Research study investigating Allogeneic NK-cell Therapy Combined with Chemotherapy for PDA or Cholangiocarcinoma

Recruiting
18 years and older
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the use of allogeneic NK-cell therapy in patients with PDA or cholangiocarcinoma. Participants will receive this therapy after undergoing surgery to remove the tumor.

The purpose of this study is to evaluate the safety and tolerability of the investigational treatment. Researchers will also assess its preliminary effectiveness when used alongside standard chemotherapy.

  • Who can participate: Adults aged 18 and older who have undergone surgery for PDA or cholangiocarcinoma may be eligible. Participants must have good overall health and specific blood test results.
  • Study details: Participants will receive investigational NK-cell therapy and chemotherapy. Some may receive a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.
  • Study timelines and visits: The study will last 12 weeks. The study requires 6 visits.
Print
Study details
    Pancreatic Carcinoma Stage II
    Cholangiocarcinoma Resectable

NCT06730009

Medigen Biotechnology Corporation

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.